4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0001193125-26-256011
Chief Financial Officer sold 40,000 shares at $70.00 ($2,800,004)
- Chief Financial Officer acquired 40,000 shares (option exercise)
- Chief Financial Officer acquired 1,268 shares (grant or award)
- Chief Financial Officer gave up 395 shares (to pay taxes)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Mokari Atabak · Chief Financial Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-01 | Exercise or conversion : show line 1 in the form 10b5-1 | +40,000 | $19.26 | $770,400 | 55,257 | D |
| 2026-06-01 | Sale : show line 2 in the form 10b5-1 | −40,000 | $70.00 | $2,800,004 | 15,257 | D |
| 2026-06-01 | Grant or award : show line 3 in the form 10b5-1 | +634 | $70.44 | $44,659 | 15,891 | D |
| 2026-06-01 | Grant or award : show line 4 in the form 10b5-1 | +634 | 16,525 | D | ||
| 2026-06-02 | Shares withheld for taxes : show line 5 in the form 10b5-1 | −395 | $70.44 | $27,824 | 16,130 | D |
| Open-market sales · 40,000 sh · avg $70.00 · $2,800,004 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-06-01 | Exercise or conversion : show line 6 in the form 10b5-1 Stock option (right to buy) | −40,000 | 60,000 | D |
Loading xslF345X06/ownership.xml…